Current filters:


Popular Filters

2125 to 2149 of 2597 results

Sandoz to emphasize need for consistent regulatory standards across all biologics at FDA hearings


Germany-based Sandoz, the generics unit of Swiss drug major Novartis (NOVN: VX) announced that Mark McCamish,…

BiotechnologyGeneralNorth AmericaNovartisRegulationResearchSandoz

Spanish reforms and generics hit Almirall's 1st-qtr; Sativex progress


Spain's leading drugmaker Almirall (ALM: MC) has reported a 5.9% decrease in sales for the first quarter…

AlmirallEuropeFinancialGW PharmaceuticalsNeurologicalPharmaceuticalRegulationSativex

Sunshine Act data collection delayed to January 2013, says USA's CMS


In a web site posting last week, The US Center for Medicare and Medicaid Services (CSM) announced that…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

FDA again rejects Alexza's Adasuve, citing manufacturing deficiencies


California, USA-based Alexza Pharmaceuticals (Nasdaq: ALXA) revealed last week that it has received another…

AdasuveAlexza PharmaceuticalNeurologicalNorth AmericaPharmaceuticalRegulation

GAO report finds that USA's FDA has met most PDUFA performance goals


A report dated March 30 but only released earlier this week by the US Government Accountability Office…

BiotechnologyNorth AmericaPharmaceuticalRegulation

New biologics and biosimilars approval guidelines in Mexico


In Mexico, new guidelines are now in effect for the market authorization of biologics and biosimilars,…

BiotechnologyGenericsRegulationSouth America

Genzyme gains FDA and EMA approval for Irish production plant


US biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN) said yesterday that…


UK MHRA seizes over £25 million of counterfeit medicine in last five years


As the UK's Medicines and Healthcare products Regulatory Agency (MHRA) launches its second anti-counterfeiting…

EuropeMarkets & MarketingPharmaceuticalRegulation

Patient perspectives influencing drug development


Support is growing for increased collaboration between pharmaceutical companies and patients in research…


Arzerra and ospemifene NDAs submitted in Japan


UK pharma giant GlaxoSmithKline (LSE: GSK) and Danish company Genmab A/S (OMX: GEN) have submitted a…

ArzerraAsia-PacificGenmabGlaxoSmithKlineOncologyospemifenePharmaceuticalQuatRx PharmaRegulationShionogiWomen's Health

Ukraine to introduce reference pricing and plans for prescription system


The Ukraine Ministry of Health and domestic producers of pharmaceuticals have signed a memorandum of…


US FDA delays Salix' Crofelemer approval


US drugmaker Salix Pharmaceuticals (Nasdaq: SLXP) revealed yesterday that the Food and Drug Administration…

crofelemerGastro-intestinalsNorth AmericaPharmaceuticalRegulationSalix Pharmaceuticals

Access to low-price generics threatened by technologies due to be used in EU


Producers of generic medicines are raising concerns on the huge cost implications of possible new anti-falsification…


Biopharmaceuticals "no longer a growth market" in Germany


After years of consistent growth, the German biopharmaceuticals market came to a juddering halt last…

BiotechnologyEuropeMarkets & MarketingPharmaceuticalPoliticsPricingRegulation

US FDA clears new ED drug Stendra


The US Food and Drug Administration late Friday gave its approval for drug developer Vivus (Nasdaq: VVUS)…

avanafilMen's HealthNorth AmericaPharmaceuticalRegulationReproductiveStendraVivus

FDA stalls Amgen's Xgeva sBLA for prevention of bone metastases


USA-based Amgen (Nasdaq: AMGN) revealed on Friday that the US Food and Drug Administration has issued…

AmgenBiotechnologyNorth AmericaOncologyRegulationXgeva

US FDA backs new indications for Votrient and Afinitor


The US Food and Drug Administration last week gave its approval for new indications for currently marketed…

AfinitorGlaxoSmithKlineNorth AmericaNovartisOncologyPharmaceuticalRegulationVotrient

US FDA again delays action on Takeda's alogliptin diabetes drug


Japan's largest drugmaker Takeda Pharmaceutical (TYO: 4502) says it has received a complete response…

ActosalogliptinDiabetesNorth AmericaPharmaceuticalRegulationTakeda Pharmaceuticals

2125 to 2149 of 2597 results

Back to top